Get startedLog in
    Picture of Ipca Laboratories logo

    IPCALAB — Ipca Laboratories Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line7,38913,81311,3577,4538,427
    Depreciation
    Non-Cash Items308-184-373-2641,326
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-4,156-4,819-4,707-1,747-3,114
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities5,64610,9018,6028,05810,212
    Capital Expenditures-3,063-3,616-4,790-4,945-4,113
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-2,034-1,591-3,761-2,305-8,805
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-5,097-5,207-8,551-7,250-12,918
    Financing Cash Flow Items-144-84.1-61.8-415-1,343
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1,305-3,0584,2685,072-5,526
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-7552,6364,3195,881-8,232